No, fexofenadine 180 mg should not be given to a 10-year-old child
The FDA-approved dose for children aged 6-11 years is fexofenadine 30 mg twice daily, not 180 mg. 1 The 180 mg dose is specifically approved only for patients 12 years and older.
Age-Appropriate Dosing for a 10-Year-Old
For a child aged 10 years with seasonal allergic rhinitis or chronic idiopathic urticaria:
- Recommended dose: 30 mg twice daily 1
- In children with decreased renal function, start with 30 mg once daily 1
The 180 mg once-daily formulation is an adult dose that should not be used in children under 12 years of age.
Why This Matters
While fexofenadine has an excellent safety profile as a second-generation antihistamine 2, dosing must be age-appropriate. The FDA label explicitly stratifies dosing by age groups, and the 180 mg dose has not been studied or approved for the 6-11 year age group 1.
Safety Profile in Children
Fexofenadine is well-tolerated in pediatric populations:
- Non-sedating with no blood-brain barrier penetration 3, 4
- Adverse events in children aged 6-11 years are similar to placebo, with headache being most common (5.8-7.2%) 5
- No cardiovascular effects or cognitive impairment 4
- Guidelines specifically note that second-generation antihistamines like fexofenadine have "very good safety profiles" in young children 2
Clinical Efficacy at Appropriate Doses
The 30 mg twice-daily dose in children aged 6-11 years:
- Significantly reduces all seasonal allergic rhinitis symptoms including nasal congestion 6, 5
- Provides exposure similar to the 60 mg adult dose when adjusted for body weight 7
- Has been validated in large multicenter trials with over 10,000 patient-days of exposure 5
Common Pitfall to Avoid
Do not extrapolate adult dosing to children based on weight alone. Pediatric pharmacokinetics differ from adults, and the 30 mg twice-daily dose has been specifically studied and approved for the 6-11 year age group. Using the 180 mg adult dose would represent a 6-fold overdose compared to the approved pediatric regimen.